
Moritz Graef
@cmgraef
ID: 1035087528557248512
30-08-2018 08:51:12
11 Tweet
72 Followers
276 Following

I am pleased to announce that our phase I clinical trial of GD2 CAR T cells for H3K27M+ DIPG and spinal diffuse midline gliomas is opening Stanford Medicine Stanford Children's. Enormously grateful to the many people who worked to make this happen.#DIPG #glioma clinicaltrials.gov/ct2/show/NCT04…

@miheger @BloodJournal Fabian Ullrich Christian Reinhardt Michael Hallek Bastian von Tresckow Congratulations! Very nice work and well-deserved.

Very happy to finally see this published. Thanks to all, esp. G. Knittel, Ruth.Fluemann and Ron Jachimowicz An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma ashpublications.org/bloodadvances/…


Great interdisciplinary collaborative effort evaluating response assessment criteria during immune checkpoint inhibition in routine care. Now published EJR_official led by Simon Lennartz Moritz Graef Uniklinik Köln link.springer.com/article/10.100…

